Press Release

Hematopoietic Stem Cell Transplantation (HSCT) Market Size Worth US$ 3.5 Bn By 2027 At A CAGR Of 11.3%

Hematopoietic stem cell transplantation (HSCT) is likely to expand rapidly due to the rising geriatric population coupled with increase in success rates of transplantation and increasing demand for high-quality healthcare services. With the increasing prevalence of hematopoietic disorders across the globe, individuals are opting for better products. Hematopoietic stem cells are also known as hematopoietic progenitor cells (HPCs), present in the bone marrow and blood. Hematopoietic stem cells can quickly produce mature blood cells, such as red blood cells, white blood cells, and platelets. These mature cells are helpful in the treatment of different types of malignant and non-malignant diseases, such as lymphoma, leukemia, hemoglobinopathies, and bone marrow failure. These cells further rebuild or replace a patient’s hematopoietic system, known as stem cell transplant or bone marrow transplant. The Global Hematopoietic Stem Cell Transplantation (HSCT) Market is estimated to see healthy growth, pegged at a CAGR of around 11.9% throughout the forecast period 2021-2027.


Allogeneic and Autologous are two types of stem cell transplants. Allogeneic HSCT is used for the replacement of diseased or damaged cells with cells from a healthy donor. It is also necessary that the donor’s tissue type be matched with the receiver’s tissue type to prevent the risk of problems with the transplant. Allogeneic transplantation involves the therapeutic intervention of patients with hematological disorders (cancerous or non-cancerous). On the other hand, the autologous HSCT replaces diseased or damaged cells with the patient’s stem cells. Before chemotherapy, harvesting of a patient’s stem cells is done, and then harvested stem cells are transplanted back into the patient after treatment. Based on the source of hematopoietic stem cells, three types of transplants are done, including peripheral blood stem cell transplant, cord blood transplant, and bone marrow transplant (BMT). 

Over the last 30 years, with advancements in lifesaving technologies, the hematopoietic stem cell transplantation market has seen a rapid expansion. Hematopoietic stem cells have also been used in clinical trials with the approval of the U.S. FDA for the treatment of genetic diseases, autoimmune diseases, and other indications. Hematopoietic stem cell transplantation helps restore the patient’s medullary and immune function and has the ability to treat a diverse range of about 70 non-hematological and hematological disorders. Overall, hematopoietic stem cell transplantation is used to treat non-malignant, hematological, malignant, immunological, oncological, and hereditary diseases. Scientists and researchers have observed that the animal studies HSCs can form other cells such as muscles, blood vessels, and bone. This will further enable the treatment of a wide array of conditions and replace ailing tissues.

Segmentation Overview of the Global Hematopoietic Stem Cell Transplantation (HSCT) Market

The hematopoietic stem cell transplantation (HSCT) market is segmented into transplant type, indication, and application. These major market segments are further categorized into various sub-segments to study the market in detail.

By Transplant Type Outlook (Allogeneic and Autologous)

By Indication Outlook (Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Hodgkin lymphoma (HL), Non-Hodgkin Lymphoma (NHL), Multiple Myeloma (MM), and Others)

By Application Outlook (Bone Marrow Transplant (BMT), Peripheral Blood Stem Cells Transplant (PBSCT), and Cord Blood Transplant (CBT))

Key Players Insights

Pluristem Therapeutics Inc., Lonza Group, Kiadis Pharma, Taiga Biotechnologies, Inc., CellGenix GmbH, Regen Biopharma Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics, Inc., Marker Therapeutics Inc., Escape Therapeutics, Inc., Bluebird Bio, and Stempeutics Research Pvt Ltd. and others, are some key market players included in the research study of the global hematopoietic stem cell transplantation (HSCT) market.

Feel Free To Ask Question Before Purchasing The Report @

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:

Nishi Sharma

Email: [email protected]

Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 – UNITED STATES

Tel: +1 888 212 3539 (US – TOLL FREE)


Tags: , , , , ,

See Campaign:
Contact Information:
+1 888 212 3539 (US – TOLL FREE)

, Reportedtimes, IPS, Menafn, Research Newswire, English


Contact Information:

+1 888 212 3539 (US – TOLL FREE)

Add Comment

Click here to post a comment

Your email address will not be published. Required fields are marked *